Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Davood Khalili, Ph.D.

Title
Institution
Department
Address

Biography
Leiden University Medical Center, Leiden, The NetherlandsVisiting Scholar2017Medical Statistics
Shahid Beheshti University of Medical Sciences, Tehran, IranPhD2012Epidemiology
Erasmus MC University, Rotterdam, The Netherlands2011Epidemiology and Biostatistics
Shahid Beheshti University of Medical Sciences, Tehran, IranMPH2008Public Health
Urmia University of Medical Sciences, Urmia, IranMD1998Medicine
2017
Honor researcher
2015
Excellent Scientist
2012
Honor researcher
2009
Honor PhD student
2008
Honor PhD student

Overview
Davood Khalili is a faculty member in the Research Institute for Endocrine Sciences, Tehran, Iran (http://endocrine.ac.ir). He is working on cardiometabolic disorders in the framework of large population-based cohort studies and clinical/community/field trials. Clinical prediction models and medical decision making are his main interests with focus on the clinical usefulness of prediction models. He is the head of the Department of Biostatistics and Epidemiology in the institute. He is also a board member of the Scientific Association for Public Health in Iran (SAPHIR, http://saphirnetwork.org) and the scientific secretariat of the Iran Cohort Consortium (ICC, http://irancohorts.ir).
He has joined the Department of Global Health and Population as a Lown Scholar in 2017.

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Farahmand M, Ramezani Tehrani F, Khalili D, Cheraghi L, Azizi F. Is there any association between age at menarche and anthropometric indices? A 15-year follow-up population-based cohort study. Eur J Pediatr. 2020 Mar 07. PMID: 32146570.
    Citations:    
  2. Amiri M, Nahidi F, Bidhendi-Yarandi R, Khalili D, Tohidi M, Ramezani Tehrani F. A comparison of the effects of oral contraceptives on the clinical and biochemical manifestations of polycystic ovary syndrome: a crossover randomized controlled trial. Hum Reprod. 2020 Jan 01; 35(1):175-186. PMID: 31916574.
    Citations:    
  3. Lee CMY, Colagiuri S, Woodward M, Gregg EW, Adams R, Azizi F, Gabriel R, Gill TK, Gonzalez C, Hodge A, Jacobs Jr DR, Joseph JJ, Khalili D, Magliano DJ, Mehlig K, Milne R, Mishra G, Mongraw-Chaffin M, Pasco JA, Sakurai M, Schreiner PJ, Selvin E, Shaw JE, Wittert G, Yatsuya H, Huxley RR. Comparing different definitions of prediabetes with subsequent risk of diabetes: an individual participant data meta-analysis involving 76 513 individuals and 8208 cases of incident diabetes. BMJ Open Diabetes Res Care. 2019; 7(1):e000794. PMID: 31908797.
    Citations:    
  4. Pahlavanzade B, Zayeri F, Baghfalaki T, Mozafari O, Khalili D, Azizi F, Abadi A. Association of lipid markers with coronary heart disease and stroke mortality: A 15-year follow-up study. Iran J Basic Med Sci. 2019 Nov; 22(11):1325-1330. PMID: 32128098.
    Citations:    
  5. Akbarpour S, Khalili D, Zeraati H, Mansournia MA, Ramezankhani A, Ahmadi Pishkuhi M, Rostami Gooran S, Fotouhi A. Relationship between lifestyle pattern and blood pressure - Iranian national survey. Sci Rep. 2019 10 23; 9(1):15194. PMID: 31645585.
    Citations:    
  6. Azizi F, Amouzegar A, Tohidi M, Hedayati M, Khalili D, Cheraghi L, Mehrabi Y, Takyar M. Increased Remission Rates After Long-Term Methimazole Therapy in Patients with Graves' Disease: Results of a Randomized Clinical Trial. Thyroid. 2019 09; 29(9):1192-1200. PMID: 31310160.
    Citations:    
  7. Azizi F, Hadaegh F, Hosseinpanah F, Mirmiran P, Amouzegar A, Abdi H, Asghari G, Parizadeh D, Montazeri SA, Lotfaliany M, Takyar F, Khalili D. Metabolic health in the Middle East and north Africa. Lancet Diabetes Endocrinol. 2019 11; 7(11):866-879. PMID: 31422063.
    Citations:    
  8. Mehran L, Yarahmadi S, Khalili D, Hedayati M, Amouzegar A, Mousapour P, Ajang N, Azizi F. Audit of the Congenital Hypothyroidism Screening Program in 15 Provinces of Iran. Arch Iran Med. 2019 06 01; 22(6):310-317. PMID: 31356097.
    Citations:    
  9. Chahardoli R, Saboor-Yaraghi AA, Amouzegar A, Khalili D, Vakili AZ, Azizi F. Can Supplementation with Vitamin D Modify Thyroid Autoantibodies (Anti-TPO Ab, Anti-Tg Ab) and Thyroid Profile (T3, T4, TSH) in Hashimoto's Thyroiditis? A Double Blind, Randomized Clinical Trial. Horm Metab Res. 2019 May; 51(5):296-301. PMID: 31071734.
    Citations:    
  10. Danaei G, Farzadfar F, Kelishadi R, Rashidian A, Rouhani OM, Ahmadnia S, Ahmadvand A, Arabi M, Ardalan A, Arhami M, Azizi MH, Bahadori M, Baumgartner J, Beheshtian A, Djalalinia S, Doshmangir L, Haghdoost AA, Haghshenas R, Hosseinpoor AR, Islami F, Kamangar F, Khalili D, Madani K, Masoumi-Asl H, Mazyaki A, Mirchi A, Moradi E, Nayernouri T, Niemeier D, Omidvari AH, Peykari N, Pishgar F, Qorbani M, Rahimi K, Rahimi-Movaghar A, Tehrani FR, Rezaei N, Shahraz S, Takian A, Tootee A, Ezzati M, Jamshidi HR, Larijani B, Majdzadeh R, Malekzadeh R. Iran in transition. Lancet. 2019 05 11; 393(10184):1984-2005. PMID: 31043324.
    Citations:    
  11. Asgari S, Khaloo P, Khalili D, Azizi F, Hadaegh F. Status of Hypertension in Tehran: Potential impact of the ACC/AHA 2017 and JNC7 Guidelines, 2012-2015. Sci Rep. 2019 04 23; 9(1):6382. PMID: 31011156.
    Citations:    
  12. Amiri P, Vahedi-Notash G, Naseri P, Khalili D, Hashemi Nazari SS, Mehrabi Y, Mahdavi Hazaveh AR, Azizi F, Hadaegh F. Correction to: National trends of pre-hypertension and hypertension among Iranian adolescents across urban and rural areas (2007-2011). Biol Sex Differ. 2019 04 15; 10(1):18. PMID: 30987682.
    Citations:    
  13. Amiri P, Vahedi-Notash G, Naseri P, Khalili D, Hashemi Nazari SS, Mehrabi Y, Mahdavi Hazaveh AR, Azizi F, Hadaegh F. National trends of pre-hypertension and hypertension among Iranian adolescents across urban and rural areas (2007-2011). Biol Sex Differ. 2019 03 29; 10(1):15. PMID: 30922399.
    Citations:    
  14. Khalili D, Asgari S, Lotfaliany M, Zafari N, Hadaegh F, Momenan AA, Nowroozpoor A, Hosseini-Esfahani F, Mirmiran P, Amiri P, Azizi F. Long-Term Effectiveness of a Lifestyle Intervention: A Pragmatic Community Trial to Prevent Metabolic Syndrome. Am J Prev Med. 2019 03; 56(3):437-446. PMID: 30777162.
    Citations:    
  15. Lotfaliany M, Hadaegh F, Asgari S, Mansournia MA, Azizi F, Oldenburg B, Khalili D. Non-invasive Risk Prediction Models in Identifying Undiagnosed Type 2 Diabetes or Predicting Future Incident Cases in the Iranian Population. Arch Iran Med. 2019 03 01; 22(3):116-124. PMID: 31029067.
    Citations:    
  16. Farahmand M, Ramezani Tehrani F, Khalili D, Cheraghi L, Bahri Khomami M, Azizi F. Association between duration of endogenous estrogen exposure and cardiovascular outcomes: A population - based cohort study. Life Sci. 2019 Mar 15; 221:335-340. PMID: 30763578.
    Citations:    
  17. Ahanchi NS, Hadaegh F, Alipour A, Ghanbarian A, Azizi F, Khalili D. Application of Latent Class Analysis to Identify Metabolic Syndrome Components Patterns in adults: Tehran Lipid and Glucose study. Sci Rep. 2019 02 07; 9(1):1572. PMID: 30733469.
    Citations:    
  18. Khajavi A, Khalili D, Azizi F, Hadaegh F. Impact of temperature and air pollution on cardiovascular disease and death in Iran: A 15-year follow-up of Tehran Lipid and Glucose Study. Sci Total Environ. 2019 Apr 15; 661:243-250. PMID: 30677672.
    Citations:    Fields:    
  19. Behboudi-Gandevani S, Ramezani Tehrani F, Hosseinpanah F, Khalili D, Cheraghi L, Kazemijaliseh H, Azizi F. Cardiometabolic risks in polycystic ovary syndrome: long-term population-based follow-up study. Fertil Steril. 2018 12; 110(7):1377-1386. PMID: 30503137.
    Citations:    
  20. Ramezankhani A, Harati H, Bozorgmanesh M, Tohidi M, Khalili D, Azizi F, Hadaegh F. Diabetes Mellitus: Findings from 20 Years of the Tehran Lipid and Glucose Study. Int J Endocrinol Metab. 2018 Oct; 16(4 Suppl):e84784. PMID: 30584445.
    Citations:    
  21. Khalili D, Azizi F, Asgari S, Zadeh-Vakili A, Momenan AA, Ghanbarian A, Eskandari F, Sheikholeslami F, Hadaegh F. Outcomes of a Longitudinal Population-based Cohort Study and Pragmatic Community Trial: Findings from 20 Years of the Tehran Lipid and Glucose Study. Int J Endocrinol Metab. 2018 Oct; 16(4 Suppl):e84748. PMID: 30584434.
    Citations:    
  22. Lotfaliany M, Akbarpour S, Zafari N, Mansournia MA, Asgari S, Azizi F, Hadaegh F, Khalili D. World Bank Income Group, Health Expenditure or Cardiometabolic Risk Factors? A Further Explanation of the Wide Gap in Cardiometabolic Mortality Between Worldwide Countries: An Ecological Study. Int J Endocrinol Metab. 2018 Jul; 16(3):e59946. PMID: 30464769.
    Citations:    
  23. Fahimfar N, Khalili D, Sepanlou SG, Malekzadeh R, Azizi F, Mansournia MA, Roohafza H, Emamian MH, Hadaegh F, Poustchi H, Mansourian M, Hashemi H, Sharafkhah M, Pourshams A, Farzadfar F, Steyerberg EW, Fotouhi A. Cardiovascular mortality in a Western Asian country: results from the Iran Cohort Consortium. BMJ Open. 2018 07 05; 8(7):e020303. PMID: 29980541.
    Citations:    Fields:    
  24. Zafari N, Lotfaliany M, Mansournia MA, Khalili D, Azizi F, Hadaegh F. Optimal cut-points of different anthropometric indices and their joint effect in prediction of type 2 diabetes: results of a cohort study. BMC Public Health. 2018 06 05; 18(1):691. PMID: 29866083.
    Citations:    Fields:    
  25. Bakhtiyari M, Schmidt N, Hadaegh F, Khalili D, Mansournia N, Asgari S, Mansournia MA. Direct and indirect effects of central and general adiposity on cardiovascular diseases: The Tehran Lipid and Glucose Study. Eur J Prev Cardiol. 2018 07; 25(11):1170-1181. PMID: 29856228.
    Citations:    Fields:    
  26. Akbarpour S, Khalili D, Zeraati H, Mansournia MA, Ramezankhani A, Fotouhi A. Healthy lifestyle behaviors and control of hypertension among adult hypertensive patients. Sci Rep. 2018 05 31; 8(1):8508. PMID: 29855520.
    Citations:    Fields:    
  27. Rabani S, Sardarinia M, Akbarpour S, Azizi F, Khalili D, Hadaegh F. 12-year trends in cardiovascular risk factors (2002-2005 through 2011-2014) in patients with cardiovascular diseases: Tehran lipid and glucose study. PLoS One. 2018; 13(5):e0195543. PMID: 29768511.
    Citations:    Fields:    Translation:Humans
  28. Amiri P, Jalali-Farahani S, Akbar HM, Cheraghi L, Khalili D, Momenan A, Mirmiran P, Ghanbarian A, Hedayati M, Hosseini-Esfahani F, Azizi F. The Effects of a Community-Based Lifestyle Intervention on Metabolic Syndrome and Its Components in Adolescents: Findings of a Decade Follow-Up. Metab Syndr Relat Disord. 2018 06; 16(5):215-223. PMID: 29648906.
    Citations: 1     Fields:    
  29. Asgari S, Abdi H, Hezaveh AM, Moghisi A, Etemad K, Beni HR, Khalili D. The Burden of Statin Therapy based on ACC/AHA and NCEP ATP-III Guidelines: An Iranian Survey of Non-Communicable Diseases Risk Factors. Sci Rep. 2018 03 21; 8(1):4928. PMID: 29563602.
    Citations:    Fields:    
  30. Mehran L, Khalili D, Yarahmadi S, Delshad H, Mehrabi Y, Amouzegar A, Ajang N, Azizi F. Evaluation of the congenital hypothyroidism screening programme in Iran: a 3-year retrospective cohort study. Arch Dis Child Fetal Neonatal Ed. 2019 Mar; 104(2):F176-F181. PMID: 29540462.
    Citations:    Fields:    
  31. Kabootari M, Asgari S, Mansournia MA, Khalili D, Valizadeh M, Azizi F, Hadaegh F. Different Weight Histories and Risk of Incident Coronary Heart Disease and Stroke: Tehran Lipid and Glucose Study. J Am Heart Assoc. 2018 02 10; 7(4). PMID: 29440011.
    Citations:    Fields:    
  32. Akbarpour S, Khalili D, Zeraati H, Mansournia MA, Ramezankhanim A, Fotouhi A. Lifestyle patterns in the Iranian population: Self- organizing map application. Caspian J Intern Med. 2018; 9(3):268-275. PMID: 30197772.
    Citations:    
  33. Kazemi Jaliseh H, Ramezani Tehrani F, Behboudi-Gandevani S, Hosseinpanah F, Khalili D, Cheraghi L, Azizi F. Polycystic ovary syndrome is a risk factor for diabetes and prediabetes in middle-aged but not elderly women: a long-term population-based follow-up study. Fertil Steril. 2017 12; 108(6):1078-1084. PMID: 29202960.
    Citations:    Fields:    Translation:Humans
  34. Kalantari S, Khalili D, Asgari S, Fahimfar N, Hadaegh F, Tohidi M, Azizi F. Predictors of early adulthood hypertension during adolescence: a population-based cohort study. BMC Public Health. 2017 11 28; 17(1):915. PMID: 29183297.
    Citations: 1     Fields:    Translation:Humans
  35. Gilani N, Kazemnejad A, Zayeri F, Hadaegh F, Azizi F, Khalili D. Anthropometric Indices as Predictors of Coronary Heart Disease Risk: Joint Modeling of Longitudinal Measurements and Time to Event. Iran J Public Health. 2017 Nov; 46(11):1546-1554. PMID: 29167774.
    Citations: 1     
  36. Mehran L, Yarahmadi S, Khalili D, Nazeri P, Delshad H, Abdollahi Z, Azhang N, Azizi F. The Impact of Iodine Status on the Recall Rate of the Screening Program for Congenital Hypothyroidism: Findings from Two National Studies in Iran. Nutrients. 2017 Oct 30; 9(11). PMID: 29084139.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  37. Amiri M, Nahidi F, Khalili D, Bidhendi-Yarandi R, Ramezani Tehrani F. Comparing the Effects of Oral Contraceptives Containing Levonorgestrel With Products Containing Antiandrogenic Progestins on Clinical, Hormonal, and Metabolic Parameters and Quality of Life in Women With Polycystic Ovary Syndrome: Crossover Randomized Controlled Trial Protocol. JMIR Res Protoc. 2017 Sep 29; 6(9):e191. PMID: 28963092.
    Citations:    
  38. Kazemijaliseh H, Ramezani Tehrani F, Behboudi-Gandevani S, Khalili D, Hosseinpanah F, Azizi F. A Population-Based Study of the Prevalence of Abnormal Uterine Bleeding and its Related Factors among Iranian Reproductive-Age Women: An Updated Data. Arch Iran Med. 2017 Sep; 20(9):558-563. PMID: 29048917.
    Citations: 1     Fields:    Translation:Humans
  39. Farahmand M, Ramezani Tehrani F, Khalili D, Amin G, Negarandeh R. Factors associated with the severity of premenstrual syndrome among Iranian college students. J Obstet Gynaecol Res. 2017 Nov; 43(11):1726-1731. PMID: 28737241.
    Citations:    Fields:    Translation:Humans
  40. Taravatmanesh S, Khalili D, Khodakarim S, Asgari S, Hadaegh F, Azizi F, Sabour S. Determining the Factors Associated with Cardiovascular Disease Recurrence: Tehran Lipid and Glucose Study. J Tehran Heart Cent. 2017 Jul; 12(3):107-113. PMID: 29062377.
    Citations:    
  41. Barzin M, Motamedi MAK, Serahati S, Khalaj A, Arian P, Valizadeh M, Khalili D, Azizi F, Hosseinpanah F. Comparison of the Effect of Gastric Bypass and Sleeve Gastrectomy on Metabolic Syndrome and its Components in a Cohort: Tehran Obesity Treatment Study (TOTS). Obes Surg. 2017 07; 27(7):1697-1704. PMID: 28054293.
    Citations:    Fields:    Translation:Humans
  42. Mehran L, Khalili D, Yarahmadi S, Amouzegar A, Mojarrad M, Ajang N, Azizi F. Worldwide Recall Rate in Newborn Screening Programs for Congenital Hypothyroidism. Int J Endocrinol Metab. 2017 Jul; 15(3):e55451. PMID: 29201074.
    Citations:    
  43. Ramezankhani A, Bagherzadeh-Khiabani F, Khalili D, Azizi F, Hadaegh F. A new look at risk patterns related to coronary heart disease incidence using survival tree analysis: 12 Years Longitudinal Study. Sci Rep. 2017 06 12; 7(1):3237. PMID: 28607472.
    Citations: 1     Fields:    
  44. Mansournia MA, Holakouie-Naieni K, Fahimfar N, Almasi-Hashiani A, Cheraghi Z, Ayubi E, Hadaegh F, Eskandari F, Azizi F, Khalili D. Risk of Coronary Heart Events Based on Rose Angina Questionnaire and ECG Besides Diabetes and Other Metabolic Risk Factors: Results of a 10-Year Follow-up in Tehran Lipid and Glucose Study. Int J Endocrinol Metab. 2017 Apr; 15(2):e42713. PMID: 28848610.
    Citations:    
  45. Daneshpour MS, Fallah MS, Sedaghati-Khayat B, Guity K, Khalili D, Hedayati M, Ebrahimi A, Hajsheikholeslami F, Mirmiran P, Ramezani Tehrani F, Momenan AA, Ghanbarian A, Amouzegar A, Amiri P, Azizi F. Rationale and Design of a Genetic Study on Cardiometabolic Risk Factors: Protocol for the Tehran Cardiometabolic Genetic Study (TCGS). JMIR Res Protoc. 2017 Feb 23; 6(2):e28. PMID: 28232301.
    Citations: 2     
  46. Golozar A, Khalili D, Etemadi A, Poustchi H, Fazeltabar A, Hosseini F, Kamangar F, Khoshnia M, Islami F, Hadaegh F, Brennan P, Boffetta P, Abnet CC, Dawsey SM, Azizi F, Malekzadeh R, Danaei G. White rice intake and incidence of type-2 diabetes: analysis of two prospective cohort studies from Iran. BMC Public Health. 2017 01 31; 17(1):133. PMID: 28137245.
    Citations: 2     Fields:    Translation:HumansAnimals
  47. Ueda P, Woodward M, Lu Y, Hajifathalian K, Al-Wotayan R, Aguilar-Salinas CA, Ahmadvand A, Azizi F, Bentham J, Cifkova R, Di Cesare M, Eriksen L, Farzadfar F, Ferguson TS, Ikeda N, Khalili D, Khang YH, Lanska V, León-Muñoz L, Magliano DJ, Margozzini P, Msyamboza KP, Mutungi G, Oh K, Oum S, Rodríguez-Artalejo F, Rojas-Martinez R, Valdivia G, Wilks R, Shaw JE, Stevens GA, Tolstrup JS, Zhou B, Salomon JA, Ezzati M, Danaei G. Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveys. Lancet Diabetes Endocrinol. 2017 03; 5(3):196-213. PMID: 28126460.
    Citations: 6     Fields:    Translation:Humans
  48. Eslami A, Mozaffary A, Derakhshan A, Azizi F, Khalili D, Hadaegh F. Sex-specific incidence rates and risk factors of premature cardiovascular disease. A long term follow up of the Tehran Lipid and Glucose Study. Int J Cardiol. 2017 Jan 15; 227:826-832. PMID: 27829526.
    Citations: 3     Fields:    Translation:Humans
  49. Panahi MH, Hadaegh F, Yavari P, Kazempour-Ardebili S, Mehrabi Y, Azizi F, Khalili D. A Challenging Interaction of Chronic Kidney Disease With Other Metabolic Disorders: Paradoxes in Cardiometabolic Risk Factors. Iran J Kidney Dis. 2016 Sep; 10(5):274-281. PMID: 27721225.
    Citations:    Fields:    Translation:Humans
  50. Cheraghi Z, Mirmiran P, Mansournia MA, Moslehi N, Khalili D, Nedjat S. The association between nutritional exposures and metabolic syndrome in the Tehran Lipid and Glucose Study (TLGS): a cohort study. Public Health. 2016 Nov; 140:163-171. PMID: 27498945.
    Citations: 1     Fields:    Translation:Humans
  51. Ghasemzadeh Z, Abdi H, Asgari S, Tohidi M, Khalili D, Valizadeh M, Moeini S, Eidkhani V, Azizi F, Hadaegh F. Divergent pathway of lipid profile components for cardiovascular disease and mortality events: Results of over a decade follow-up among Iranian population. Nutr Metab (Lond). 2016; 13:43. PMID: 27346994.
    Citations: 2     
  52. Helgadottir A, Gretarsdottir S, Thorleifsson G, Hjartarson E, Sigurdsson A, Magnusdottir A, Jonasdottir A, Kristjansson H, Sulem P, Oddsson A, Sveinbjornsson G, Steinthorsdottir V, Rafnar T, Masson G, Jonsdottir I, Olafsson I, Eyjolfsson GI, Sigurdardottir O, Daneshpour MS, Khalili D, Azizi F, Swinkels DW, Kiemeney L, Quyyumi AA, Levey AI, Patel RS, Hayek SS, Gudmundsdottir IJ, Thorgeirsson G, Thorsteinsdottir U, Gudbjartsson DF, Holm H, Stefansson K. Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease. Nat Genet. 2016 06; 48(6):634-9. PMID: 27135400.
    Citations: 43     Fields:    Translation:Humans
  53. Asgari S, Barzin M, Hosseinpanah F, Hadaegh F, Azizi F, Khalili D. Obesity Paradox and Recurrent Coronary Heart Disease in a Population-Based Study: Tehran Lipid and Glucose Study. Int J Endocrinol Metab. 2016 Apr; 14(2):e37018. PMID: 27761144.
    Citations: 1     
  54. Afsharian S, Akbarpour S, Abdi H, Sheikholeslami F, Moeini AS, Khalili D, Momenan AA, Azizi F, Hadaegh F. Risk factors for cardiovascular disease and mortality events in adults with type 2 diabetes?-?a 10-year follow-up: Tehran Lipid and Glucose Study. Diabetes Metab Res Rev. 2016 09; 32(6):596-606. PMID: 26787367.
    Citations: 3     Fields:    Translation:Humans
  55. Bagherzadeh-Khiabani F, Steyerberg EW, Khalili D. The authors' reply to letter to the editor re: Bagherzadeh-Khiabani et al., J Clin Epi, 2015. J Clin Epidemiol. 2016 07; 75:131-2. PMID: 26939930.
    Citations:    Fields:    
  56. Hadaegh F, Derakhshan A, Mozaffary A, Hasheminia M, Khalili D, Azizi F. Twelve-Year Cardiovascular and Mortality Risk in Relation to Smoking Habits in Type 2 Diabetic and Non-Diabetic Men: Tehran Lipid and Glucose Study. PLoS One. 2016; 11(3):e0149780. PMID: 26930192.
    Citations: 3     Fields:    Translation:Humans
  57. Barzin M, Hosseinpanah F, Motamedi MA, Shapoori P, Arian P, Daneshpour MA, Asghari G, Teymoornejad A, Eslamifar A, Khalili D, Jodeiri B, Alamdari S, Azizi F, Khalaj A. Bariatric Surgery for Morbid Obesity: Tehran Obesity Treatment Study (TOTS) Rationale and Study Design. JMIR Res Protoc. 2016 Jan 20; 5(1):e8. PMID: 26792554.
    Citations: 6     
  58. Asgari S, Khalili D, Mehrabi Y, Kazempour-Ardebili S, Azizi F, Hadaegh F. Incidence and risk factors of isolated systolic and diastolic hypertension: a 10 year follow-up of the Tehran Lipids and Glucose Study. Blood Press. 2016 Jun; 25(3):177-83. PMID: 26643588.
    Citations: 3     Fields:    Translation:Humans
  59. Bagherzadeh-Khiabani F, Ramezankhani A, Azizi F, Hadaegh F, Steyerberg EW, Khalili D. A tutorial on variable selection for clinical prediction models: feature selection methods in data mining could improve the results. J Clin Epidemiol. 2016 Mar; 71:76-85. PMID: 26475568.
    Citations: 7     Fields:    Translation:Humans
  60. Hadaegh F, Hasheminia M, Abdi H, Khalili D, Bozorgmanesh M, Arshi B, Azizi F. Prehypertension Tsunami: A Decade Follow-Up of an Iranian Adult Population. PLoS One. 2015; 10(10):e0139412. PMID: 26439847.
    Citations: 2     Fields:    Translation:Humans
  61. Masudi S, Yavari P, Mehrabi Y, Azizi F, Khalili D, Hadaegh F. Underestimating the Effect of Lipids on Cardiovascular Events: Regression Dilution Bias in the Population-Based Cohort of Tehran Lipid and Glucose Study. Int J Endocrinol Metab. 2015 Oct; 13(4):e27528. PMID: 26587030.
    Citations: 1     
  62. Khalili M, Vasei M, Khalili D, Alimoghaddam K, Sadeghizadeh M, Mowla SJ. Downregulation of the Genes Involved in Reprogramming (SOX2, c-MYC, miR-302, miR-145, and P21) in Gastric Adenocarcinoma. J Gastrointest Cancer. 2015 Sep; 46(3):251-8. PMID: 25904219.
    Citations: 8     Fields:    Translation:HumansCells
  63. Hashemi Nazari SS, Shakiba M, Khalili D, Hadaegh F, Tohidi M, Azizi F. High-density lipoprotein cholesterol, a protective or a risk factor for developing coronary heart disease? Tehran Lipid and Glucose Study. J Clin Lipidol. 2015 Jul-Aug; 9(4):553-8. PMID: 26228673.
    Citations: 1     Fields:    Translation:Humans
  64. Kazemijaliseh H, Ramezani Tehrani F, Behboudi-Gandevani S, Hosseinpanah F, Khalili D, Azizi F. The Prevalence and Causes of Primary Infertility in Iran: A Population-Based Study. Glob J Health Sci. 2015 Apr 19; 7(6):226-32. PMID: 26153187.
    Citations: 7     Fields:    Translation:Humans
  65. Hajifathalian K, Ueda P, Lu Y, Woodward M, Ahmadvand A, Aguilar-Salinas CA, Azizi F, Cifkova R, Di Cesare M, Eriksen L, Farzadfar F, Ikeda N, Khalili D, Khang YH, Lanska V, León-Muñoz L, Magliano D, Msyamboza KP, Oh K, Rodríguez-Artalejo F, Rojas-Martinez R, Shaw JE, Stevens GA, Tolstrup J, Zhou B, Salomon JA, Ezzati M, Danaei G. A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys. Lancet Diabetes Endocrinol. 2015 May; 3(5):339-55. PMID: 25819778.
    Citations: 21     Fields:    Translation:Humans
  66. Khalili D, Asgari S, Hadaegh F, Steyerberg EW, Rahimi K, Fahimfar N, Azizi F. A new approach to test validity and clinical usefulness of the 2013 ACC/AHA guideline on statin therapy: A population-based study. Int J Cardiol. 2015 Apr 01; 184:587-94. PMID: 25769004.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  67. Ayubi E, Khalili D, Delpisheh A, Hadaegh F, Azizi F. Factor analysis of metabolic syndrome components and predicting type 2 diabetes: Results of 10-year follow-up in a Middle Eastern population. J Diabetes. 2015 Nov; 7(6):830-8. PMID: 25492310.
    Citations: 4     Fields:    Translation:Humans
  68. Masudi S, Yavari P, Mehrabi Y, Khalili D, Azizi F. Regression dilution bias in blood pressure and body mass index in a longitudinal population-based cohort study. J Res Health Sci. 2015; 15(2):77-82. PMID: 26175288.
    Citations: 1     Fields:    Translation:Humans
  69. Azimi SS, Khalili D, Hadaegh F, Yavari P, Mehrabi Y, Azizi F. Calculating population attributable fraction for cardiovascular risk factors using different methods in a population based cohort study. J Res Health Sci. 2015; 15(1):22-7. PMID: 25821021.
    Citations: 1     Fields:    Translation:Humans
  70. Jahangiri-Noudeh Y, Akbarpour S, Lotfaliany M, Zafari N, Khalili D, Tohidi M, Mansournia MA, Azizi F, Hadaegh F. Trends in cardiovascular disease risk factors in people with and without diabetes mellitus: a Middle Eastern cohort study. PLoS One. 2014; 9(12):e112639. PMID: 25461381.
    Citations: 7     Fields:    Translation:Humans
  71. Ramezankhani A, Pournik O, Shahrabi J, Azizi F, Hadaegh F, Khalili D. The Impact of Oversampling with SMOTE on the Performance of 3 Classifiers in Prediction of Type 2 Diabetes. Med Decis Making. 2016 01; 36(1):137-44. PMID: 25449060.
    Citations: 3     Fields:    Translation:Humans
  72. Khalili D, Sheikholeslami FH, Bakhtiyari M, Azizi F, Momenan AA, Hadaegh F. The incidence of coronary heart disease and the population attributable fraction of its risk factors in Tehran: a 10-year population-based cohort study. PLoS One. 2014; 9(8):e105804. PMID: 25162590.
    Citations: 10     Fields:    Translation:Humans
  73. Ramezankhani A, Pournik O, Shahrabi J, Khalili D, Azizi F, Hadaegh F. Applying decision tree for identification of a low risk population for type 2 diabetes. Tehran Lipid and Glucose Study. Diabetes Res Clin Pract. 2014 Sep; 105(3):391-8. PMID: 25085758.
    Citations: 4     Fields:    Translation:Humans
  74. Derakhshan A, Sardarinia M, Khalili D, Momenan AA, Azizi F, Hadaegh F. Sex specific incidence rates of type 2 diabetes and its risk factors over 9 years of follow-up: Tehran Lipid and Glucose Study. PLoS One. 2014; 9(7):e102563. PMID: 25029368.
    Citations: 16     Fields:    Translation:Humans
  75. Kabir A, Khalili D. Built-in bias in HCV clearance in acute HCV infection. J Hepatol. 2014 Feb; 60(2):461. PMID: 24161407.
    Citations:    Fields:    Translation:Humans
  76. Khalili D, Hadaegh F, Steyerberg EW. The authors reply. Am J Epidemiol. 2013 Apr 15; 177(8):865-6. PMID: 23705141.
    Citations:    Fields:    Translation:Humans
  77. Jahangiri Noudeh Y, Hadaegh F, Vatankhah N, Momenan AA, Saadat N, Khalili D, Azizi F. Wrist circumference as a novel predictor of diabetes and prediabetes: results of cross-sectional and 8.8-year follow-up studies. J Clin Endocrinol Metab. 2013 Feb; 98(2):777-84. PMID: 23341488.
    Citations: 11     Fields:    Translation:Humans
  78. Hadaegh F, Jahangiri Noudeh Y, Tohidi M, Vatankhah N, Khalili D, Mohebi R, Azizi F. Change in general and central adiposity measures in prediction of incident dysglycemia; Tehran Lipid and Glucose Study. Prev Med. 2012 Dec; 55(6):608-12. PMID: 23046898.
    Citations: 2     Fields:    Translation:Humans
  79. Fahimfar N, Khalili D, Mohebi R, Azizi F, Hadaegh F. Risk factors for ischemic stroke; results from 9 years of follow-up in a population based cohort of Iran. BMC Neurol. 2012 Oct 02; 12:117. PMID: 23031547.
    Citations: 9     Fields:    Translation:Humans
  80. Tohidi M, Hasheminia M, Mohebi R, Khalili D, Hosseinpanah F, Yazdani B, Nasiri AA, Azizi F, Hadaegh F. Incidence of chronic kidney disease and its risk factors, results of over 10 year follow up in an Iranian cohort. PLoS One. 2012; 7(9):e45304. PMID: 23028919.
    Citations: 18     Fields:    Translation:Humans
  81. Hatami M, Tohidi M, Mohebi R, Khalili D, Azizi F, Hadaegh F. Adolescent lipoprotein classifications according to National Health and Nutrition Examination Survey (NHANES) vs. National Cholesterol Education Program (NCEP) for predicting abnormal lipid levels in adulthood in a Middle East population. Lipids Health Dis. 2012 Aug 31; 11:107. PMID: 22937812.
    Citations: 1     Fields:    Translation:Humans
  82. Khalili D, Hadaegh F, Soori H, Steyerberg EW, Bozorgmanesh M, Azizi F. Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance: the Tehran Lipid and Glucose Study. Am J Epidemiol. 2012 Aug 01; 176(3):177-86. PMID: 22814370.
    Citations: 15     Fields:    Translation:Humans
  83. Khalili D, Hadaegh F, Fahimfar N, Shafiee G, Sheikholeslami F, Ghanbarian A, Azizi F. Does an electrocardiogram add predictive value to the rose angina questionnaire for future coronary heart disease? 10-year follow-up in a Middle East population. J Epidemiol Community Health. 2012 Dec; 66(12):1104-9. PMID: 22544919.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  84. Khalili D, Mosavi-Jarrahi A, Eskandari F, Mousavi-Jarrahi Y, Hadaegh F, Mohagheghi M, Azizi F. Evaluation of cause of deaths' validity using outcome measures from a prospective, population based cohort study in Tehran, Iran. PLoS One. 2012; 7(2):e31427. PMID: 22355365.
    Citations: 6     Fields:    Translation:Humans
  85. Samadi S, Bozorgmanesh M, Khalili D, Momenan A, Sheikholeslami F, Azizi F, Hadaegh F. Hypertriglyceridemic waist: the point of divergence for prediction of CVD vs. mortality: Tehran Lipid and Glucose Study. Int J Cardiol. 2013 May 10; 165(2):260-5. PMID: 21924777.
    Citations: 3     Fields:    Translation:Humans
  86. Hadaegh F, Bozorgmanesh M, Safarkhani M, Khalili D, Azizi F. "Predictability of body mass index for diabetes: affected by the presence of metabolic syndrome?". BMC Public Health. 2011 May 25; 11:383. PMID: 21609497.
    Citations: 7     Fields:    Translation:Humans
  87. Solaymani-Dodaran M, Khalili D, Hosseini H, Najafi L, Kamali K, Ranjbar P, Tavakoli H, Ostovar A. Iranian Registry of Clinical Trials two years on and the timing of registrations. J Evid Based Med. 2011; 4(3):168-71. PMID: 23672721.
    Citations: 2     Fields:    Translation:Humans
  88. Hadaegh F, Fahimfar N, Khalili D, Sheikholeslami F, Azizi F. New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a Middle East population. Cardiovasc Diabetol. 2010 Dec 04; 9:84. PMID: 21129219.
    Citations: 17     Fields:    Translation:Humans
  89. Azizi F, Hadaegh F, Khalili D, Esteghamati A, Hosseinpanah F, Delavari A, Larijani B, Mirmiran P, Zabetian A, Mehrabi Y, Kelishadi R, Aghajani H. Appropriate definition of metabolic syndrome among Iranian adults: report of the Iranian National Committee of Obesity. Arch Iran Med. 2010 Sep; 13(5):426-8. PMID: 20804311.
    Citations: 41     Fields:    Translation:Humans
  90. Azizi F, Khalili D, Aghajani H, Esteghamati A, Hosseinpanah F, Delavari A, Larijani B, Mirmiran P, Mehrabi Y, Kelishadi R, Hadaegh F. Appropriate waist circumference cut-off points among Iranian adults: the first report of the Iranian National Committee of Obesity. Arch Iran Med. 2010 May; 13(3):243-4. PMID: 20433230.
    Citations: 35     Fields:    Translation:Humans
  91. Solaymani-Dodaran M, Ostovar A, Khalili D, Vasei M. Iranian Registry of Clinical Trials: path and challenges from conception to a World Health Organization primary register. J Evid Based Med. 2009 Feb; 2(1):32-5. PMID: 21348980.
    Citations: 4     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu).
Khalili's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (203)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.